Changshu Enzyme Biotechnology Co., Ltd. is a wholly-owned company of Gene Port (Hong Kong) Holdings Limited. The registered capital is 50 million rmb, with a total investment of 150 million rmb. The company covers a total area of 22522 square meters, with a total construction area of 17958 square meters after completion. It has established two production workshops and supporting analysis and testing centers, as well as supporting facilities such as offices and sewage treatment centers. Changshu Ensai Biotechnology Co., Ltd. relies on the unique new solid-phase enzyme technology of Gene Port (Hong Kong) Holdings Limited to synthesize and produce reduced glutathione.